Elypta participated in the Serendipity Challenge finals at Techarenan in Almedalen, Visby - a focal point for Swedish industry and policymakers at an annual gathering in July every year. Elypta was one of 50 selected start-ups among over 400 applicants.
Following initial pitches to a jury of investors and subsequent presentations by the top 7 companies to the audience at Techarenan, Elypta was awarded Nordic Start-up of the year for its rapid progress towards introducing novel biomarkers for early detection of cancer. The competition is in its 5th year and attracts start-ups from across sectors, focusing on Tech.
The award is a great recognition for the efforts of the team over the last year.
